Osang Jiel, Subsidiary Osang Healthcare Secures Large-Scale European Order for COVID-19 Diagnostic Kits

[Asia Economy Reporter Oh Ju-yeon] Osang Healthcare, a subsidiary of Osang Jaeil, announced on the 20th that it has signed an export contract for 2.5 million test units with Italy and Romania and is shipping products weekly.

An Osang Healthcare official stated, "In Europe, where the spread of the novel coronavirus infection (COVID-19) is rapidly increasing, export inquiries are flooding not only from Italy but also from Eastern European countries," adding, "The export volume contracted with Italy and Romania is being shipped on a weekly basis, and we have completed the establishment of a production system to ensure there are no issues with production even for large additional orders."

According to the company, in the early stages of the COVID-19 crisis, diagnostic testing usually took 1 to 2 days. However, the real-time polymerase chain reaction (RT-PCR) diagnostic kits developed by domestic companies can diagnose within 6 hours, leading Korean COVID-19 diagnostic kits to now attract attention from countries around the world. The company added that even the United States, where a member of the House of Representatives had previously stated that Korean diagnostic kits were inadequate, is now sending love calls to domestic diagnostic kit companies.

An Osang Healthcare official said, "We have already submitted the final documents, including supplementary materials requested during the current FDA review process in the U.S., and we expect to confirm the results of the FDA emergency use authorization application soon."

This content was produced with the assistance of AI translation services.